WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed
WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed
WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed
Thousands competed in the 15th edition of World Class for the coveted title SHANGHAI, Sept. 12, 2024 (GLOBE NEWSWIRE) —
Thousands competed in the 15th edition of World Class for the coveted title SHANGHAI, Sept. 12, 2024 (GLOBE NEWSWIRE) —
Thousands competed in the 15th edition of World Class for the coveted title SHANGHAI, Sept. 12, 2024 (GLOBE NEWSWIRE) —
Thousands competed in the 15th edition of World Class for the coveted title SHANGHAI, Sept. 12, 2024 (GLOBE NEWSWIRE) —
Thousands competed in the 15th edition of World Class for the coveted title SHANGHAI, Sept. 12, 2024 (GLOBE NEWSWIRE) —
Thousands competed in the 15th edition of World Class for the coveted title SHANGHAI, Sept. 12, 2024 (GLOBE NEWSWIRE) —